{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:56:07Z","timestamp":1791644167280,"version":"4.3.4"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"name":"institutional"},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Alteration in metabolic activities is a critical step in cancer progression. Myriad metabolic-based therapy options are increasingly being proposed for human tumours. However, emerging evidence highlights interpatient metabolic heterogeneity and underscores the importance of metabolic phenotyping in cancer treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate metabolic heterogeneity in cutaneous squamous cell carcinoma (cSCC) and its impact on cSCC characteristics and treatment responses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We applied combined proteomic and bioenergetic analyses to patient samples representing various stages of cSCC, ranging from precancerous actinic keratosis to metastatic cSCC. To investigate the functional impacts of the identified metabolic heterogeneities on tumour characteristics and treatment responses, we used patient-derived tumour cell (PDC) and patient-derived xenograft (PDX) models by transplanting tumour cells and freshly resected patient tumours into immunocompromised mice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Three subgroups with low, medium and high metabolic scores, respectively, were identified across all stages of carcinogenesis. Functional analyses indicated that, in both models (PDC and PDX), the sensitivities of tumours to leflunomide, an inhibitor of dihydroorotate dehydrogenase (DHODH), were inversely correlated with their metabolic scores and directly correlated with DHODH protein expression level. Moreover, DHODH overexpression in nonresponding groups rendered them sensitive to leflunomide.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The findings demonstrate the relevance of metabolic profiling and scoring in the design of therapeutic approaches targeting the bioenergetic vulnerabilities of tumours and suggest DHODH as a promising therapeutic target in the low metabolic score subgroup of cSCC.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljaf253","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T14:54:38Z","timestamp":1751036078000},"page":"936-947","source":"Crossref","is-referenced-by-count":5,"title":["Metabolism-based scoring of cutaneous squamous cell carcinoma to predict tumour features and responses to treatment with dihydroorotate dehydrogenase inhibitors"],"prefix":"10.1093","volume":"193","author":[{"given":"Lea","family":"Dousset","sequence":"first","affiliation":[{"name":"University of Bordeaux , Inserm, BRIC, UMR 1312, Bordeaux ,","place":["France"]},{"name":"Dermatology Department, Bordeaux University Hospital , Saint-Andr\u00e9 Hospital, Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferial","family":"Khalife","sequence":"additional","affiliation":[{"name":"University of Bordeaux , Inserm, BRIC, UMR 1312, Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0588-9630","authenticated-orcid":false,"given":"Domitille","family":"Chalopin-Fillot","sequence":"additional","affiliation":[{"name":"University of Bordeaux , CNRS, IBGC, UMR 5095, Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1882-123X","authenticated-orcid":false,"given":"Benjamin","family":"Dartigues","sequence":"additional","affiliation":[{"name":"University of Bordeaux , CNRS, IBGC, UMR 5095, Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Naji","sequence":"additional","affiliation":[{"name":"University of Bordeaux , Inserm, BRIC, UMR 1312, Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Mahfouf","sequence":"additional","affiliation":[{"name":"University of Bordeaux , Inserm, BRIC, UMR 1312, Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Muzotte","sequence":"additional","affiliation":[{"name":"University of Bordeaux , Inserm, BRIC, UMR 1312, Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Rousseau","sequence":"additional","affiliation":[{"name":"Animalerie A2, University of Bordeaux , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8666-6430","authenticated-orcid":false,"given":"Nivea","family":"Amoedo","sequence":"additional","affiliation":[{"name":"Inserm U1211 Maladies Rares: G\u00e9n\u00e9tique et M\u00e9tabolisme (MRGM), University of Bordeaux , Bordeaux ,","place":["France"]},{"name":"CELLOMET, Bordeaux Centre of Functional Genomics, University of Bordeaux , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5315-2823","authenticated-orcid":false,"given":"St\u00e9phane","family":"Claverol","sequence":"additional","affiliation":[{"name":"University of Bordeaux , Bordeaux Proteome, Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Bondaz","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, University of Bordeaux , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Beltzung","sequence":"additional","affiliation":[{"name":"Pathology Department, Bordeaux University Hospital , Haut-L\u00e9v\u00eaque Hospital, Pessac ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0048-6501","authenticated-orcid":false,"given":"Marie-Laure","family":"Jullie","sequence":"additional","affiliation":[{"name":"Pathology Department, Bordeaux University Hospital , Haut-L\u00e9v\u00eaque Hospital, Pessac ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Vergier","sequence":"additional","affiliation":[{"name":"Pathology Department, Bordeaux University Hospital , Haut-L\u00e9v\u00eaque Hospital, Pessac ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0928-8608","authenticated-orcid":false,"given":"Alain","family":"Taieb","sequence":"additional","affiliation":[{"name":"University of Bordeaux , Inserm, BRIC, UMR 1312, Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7642-3550","authenticated-orcid":false,"given":"Laure","family":"Favot-Laforge","sequence":"additional","affiliation":[{"name":"LITEC UR15560 , Poitiers ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigue","family":"Rossignol","sequence":"additional","affiliation":[{"name":"Inserm U1211 Maladies Rares: G\u00e9n\u00e9tique et M\u00e9tabolisme (MRGM), University of Bordeaux , Bordeaux ,","place":["France"]},{"name":"CELLOMET, Bordeaux Centre of Functional Genomics, University of Bordeaux , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6150-1229","authenticated-orcid":false,"given":"Marie","family":"Beylot-Barry","sequence":"additional","affiliation":[{"name":"University of Bordeaux , Inserm, BRIC, UMR 1312, Bordeaux ,","place":["France"]},{"name":"Dermatology Department, Bordeaux University Hospital , Saint-Andr\u00e9 Hospital, Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6059-577X","authenticated-orcid":false,"given":"Macha","family":"Nikolski","sequence":"additional","affiliation":[{"name":"University of Bordeaux , CNRS, IBGC, UMR 5095, Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8067-1338","authenticated-orcid":false,"given":"Hamid-Reza","family":"Rezvani","sequence":"additional","affiliation":[{"name":"University of Bordeaux , Inserm, BRIC, UMR 1312, Bordeaux ,","place":["France"]},{"name":"Aquiderm, University of Bordeaux , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"2025101708281249700_ljaf253-B1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"key":"2025101708281249700_ljaf253-B2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.sder.2011.01.002","article-title":"No end in sight: the skin cancer epidemic continues","volume":"30","author":"Donaldson","year":"2011","journal-title":"Semin Cutan Med Surg"},{"key":"2025101708281249700_ljaf253-B3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1172\/JCI57415","article-title":"From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma","volume":"122","author":"Ratushny","year":"2012","journal-title":"J Clin Invest"},{"key":"2025101708281249700_ljaf253-B4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"key":"2025101708281249700_ljaf253-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers14030629","article-title":"Update on management recommendations for advanced cutaneous squamous cell carcinoma","volume":"14","author":"Garc\u00eda-Foncillas","year":"2022","journal-title":"Cancers"},{"key":"2025101708281249700_ljaf253-B6","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/jdv.19897","article-title":"European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Europ\u00e9enne des M\u00e9decins Sp\u00e9cialistes)","volume":"38","author":"Kandolf","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025101708281249700_ljaf253-B7","doi-asserted-by":"crossref","first-page":"113251","DOI":"10.1016\/j.ejca.2023.113251","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention \u2013 update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur J Cancer"},{"key":"2025101708281249700_ljaf253-B8","doi-asserted-by":"crossref","first-page":"113252","DOI":"10.1016\/j.ejca.2023.113252","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment \u2013 update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur J Cancer"},{"key":"2025101708281249700_ljaf253-B9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/cancers14030550","article-title":"Recent advanced in the treatment of advanced SCC tumors","volume":"14","author":"Basset-Seguin","year":"2022","journal-title":"Cancers"},{"key":"2025101708281249700_ljaf253-B10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejca.2018.01.075","article-title":"Advanced cutaneous squamous cell carcinoma: a retrospective analysis of patient profiles and treatment patterns \u2013 results of a non-interventional study of the DeCOG","volume":"96","author":"Hillen","year":"2018","journal-title":"Eur J Cancer"},{"key":"2025101708281249700_ljaf253-B11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/ars.2016.6750","article-title":"Heterogeneity in cancer metabolism: new concepts in an old field","volume":"26","author":"Gentric","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"2025101708281249700_ljaf253-B12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biocel.2014.12.008","article-title":"Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy","volume":"59","author":"Obre","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"2025101708281249700_ljaf253-B13","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.bbabio.2017.01.013","article-title":"Energy metabolism in skin cancers: a therapeutic perspective","volume":"1858","author":"Hosseini","year":"2017","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"2025101708281249700_ljaf253-B14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"2025101708281249700_ljaf253-B15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"2025101708281249700_ljaf253-B16","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.biocel.2010.05.003","article-title":"Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells","volume":"43","author":"Smolkova","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"2025101708281249700_ljaf253-B17","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1016\/j.celrep.2018.05.060","article-title":"Energy metabolism rewiring precedes UVB-induced primary skin tumor formation","volume":"23","author":"Hosseini","year":"2018","journal-title":"Cell Rep"},{"key":"2025101708281249700_ljaf253-B18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial metabolism as a target for cancer therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell metabolism"},{"key":"2025101708281249700_ljaf253-B19","first-page":"222","article-title":"Leflunomide Aventis Pharma","volume":"2","author":"Kaplan","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"2025101708281249700_ljaf253-B20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1358\/dot.2000.36.6.584259","article-title":"Leflunomide: efficacy and safety in clinical trials for the treatment of rheumatoid arthritis","volume":"36","author":"Schiff","year":"2000","journal-title":"Drugs Today (Barc)"},{"key":"2025101708281249700_ljaf253-B21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41389-019-0161-z","article-title":"UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesis","volume":"8","author":"Hosseini","year":"2019","journal-title":"Oncogenesis"},{"key":"2025101708281249700_ljaf253-B22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cmet.2019.08.013","article-title":"Mechanisms and implications of metabolic heterogeneity in cancer","volume":"30","author":"Kim","year":"2019","journal-title":"Cell Metab"},{"key":"2025101708281249700_ljaf253-B23","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1186\/s12885-019-6418-2","article-title":"Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification","volume":"19","author":"Zoni","year":"2019","journal-title":"BMC Cancer"},{"key":"2025101708281249700_ljaf253-B24","doi-asserted-by":"crossref","first-page":"e133081","DOI":"10.1172\/JCI133081","article-title":"Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas","volume":"131","author":"Amoedo","year":"2021","journal-title":"J Clin Invest"},{"key":"2025101708281249700_ljaf253-B25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","article-title":"Metabolic heterogeneity in human lung tumors","volume":"164","author":"Hensley","year":"2016","journal-title":"Cell"},{"key":"2025101708281249700_ljaf253-B26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cmet.2018.09.002","article-title":"PML-regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers","volume":"29","author":"Gentric","year":"2019","journal-title":"Cell Metab"},{"key":"2025101708281249700_ljaf253-B27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12859-022-04828-2","article-title":"orsum: a Python package for filtering and comparing enrichment analyses using a simple principle","volume":"23","author":"Ozisik","year":"2022","journal-title":"BMC Bioinformatics"},{"key":"2025101708281249700_ljaf253-B28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.asej.2014.04.011","article-title":"Sentiment analysis algorithms and applications: a survey","volume":"5","author":"Medhat","year":"2014","journal-title":"Ain Shams Eng J"},{"key":"2025101708281249700_ljaf253-B29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/bib\/bbx085","article-title":"The BioCyc collection of microbial genomes and metabolic pathways","volume":"20","author":"Karp","year":"2019","journal-title":"Brief Bioinform"},{"key":"2025101708281249700_ljaf253-B30","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","article-title":"Genomic analysis of metastatic cutaneous squamous cell carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2025101708281249700_ljaf253-B31","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-14-1768","article-title":"Mutational landscape of aggressive cutaneous squamous cell carcinoma","volume":"20","author":"Pickering","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2025101708281249700_ljaf253-B32","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat Commun"},{"key":"2025101708281249700_ljaf253-B33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000051637","article-title":"Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin","volume":"202","author":"Shimizu","year":"2001","journal-title":"Dermatology"},{"key":"2025101708281249700_ljaf253-B34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","article-title":"Integrated proteogenomic characterization of human high-grade serous ovarian cancer","volume":"166","author":"Zhang","year":"2016","journal-title":"Cell"},{"key":"2025101708281249700_ljaf253-B35","first-page":"3521","article-title":"Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium","volume":"52","author":"Chen","year":"1992","journal-title":"Cancer Res"},{"key":"2025101708281249700_ljaf253-B36","first-page":"5563","article-title":"Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2\u2019-fluoro-1,1\u2019-biphenyl-4-yl)-3-methyl-4-quinolinecarboxylic acid sodium salt], against experimental tumors","volume":"45","author":"Dexter","year":"1985","journal-title":"Cancer Res"},{"key":"2025101708281249700_ljaf253-B37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0304-3835(90)90149-R","article-title":"Antitumor activity of brequinar sodium (Dup-785) against human head and neck squamous cell carcinoma xenografts","volume":"49","author":"Braakhuis","year":"1990","journal-title":"Cancer Lett"},{"key":"2025101708281249700_ljaf253-B38","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.18632\/oncotarget.23378","article-title":"The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth","volume":"9","author":"Hanson","year":"2017","journal-title":"Oncotarget"},{"key":"2025101708281249700_ljaf253-B39","first-page":"2931","article-title":"Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts","volume":"6","author":"Strawn","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2025101708281249700_ljaf253-B40","first-page":"4644","article-title":"In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients","volume":"50","author":"Peters","year":"1990","journal-title":"Cancer Res"},{"key":"2025101708281249700_ljaf253-B41","first-page":"4648","article-title":"Phase I clinical and pharmacokinetic trial of brequinar sodium (DUP 785; NSC 368390)","volume":"49","author":"Shen","year":"1989","journal-title":"Cancer Res"},{"key":"2025101708281249700_ljaf253-B42","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/0277-5379(89)90334-9","article-title":"Pharmacokinetics of brequinar sodium (NSC 368390) in patients with solid tumors during a phase I study","volume":"25","author":"Schwartsmann","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2025101708281249700_ljaf253-B43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2016.08.057","article-title":"Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia","volume":"167","author":"Sykes","year":"2016","journal-title":"Cell"},{"key":"2025101708281249700_ljaf253-B44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1158\/2159-8290.CD-16-0611","article-title":"Adaptive reprogramming of de novo pyrimidine synthesis is a metabolic vulnerability in triple-negative breast cancer","volume":"7","author":"Brown","year":"2017","journal-title":"Cancer Discov"},{"key":"2025101708281249700_ljaf253-B45","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chembiol.2018.03.005","article-title":"Dependence on the pyrimidine biosynthetic enzyme DHODH is a synthetic lethal vulnerability in mutant KRAS-driven cancers","volume":"25","author":"Koundinya","year":"2018","journal-title":"Cell Chem Biol"},{"key":"2025101708281249700_ljaf253-B46","doi-asserted-by":"crossref","first-page":"eaau4972","DOI":"10.1126\/scitranslmed.aau4972","article-title":"Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells","volume":"11","author":"Wang","year":"2019","journal-title":"Sci Transl Med"},{"key":"2025101708281249700_ljaf253-B47","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature09882","article-title":"DHODH modulates transcriptional elongation in the neural crest and melanoma","volume":"471","author":"White","year":"2011","journal-title":"Nature"},{"key":"2025101708281249700_ljaf253-B48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41368-020-00109-x","article-title":"SOX2-dependent expression of dihydroorotate dehydrogenase regulates oral squamous cell carcinoma cell proliferation","volume":"13","author":"Qiu","year":"2021","journal-title":"Int J Oral Sci"},{"key":"2025101708281249700_ljaf253-B49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biochi.2017.02.003","article-title":"Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cells","volume":"135","author":"Mohamad Fairus","year":"2017","journal-title":"Biochimie"},{"key":"2025101708281249700_ljaf253-B50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.freeradbiomed.2024.12.030","article-title":"Energy metabolism rewiring following acute UVB irradiation is largely dependent on nuclear DNA damage","volume":"227","author":"Dousset","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"2025101708281249700_ljaf253-B51","doi-asserted-by":"crossref","first-page":"e52135","DOI":"10.7554\/eLife.52135","article-title":"PCK1 and DHODH drive colorectal cancer liver metastatic colonization and hypoxic growth by promoting nucleotide synthesis","volume":"8","author":"Yamaguchi","year":"2019","journal-title":"Elife"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf253\/63613525\/ljaf253.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/5\/936\/63613525\/ljaf253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/5\/936\/63613525\/ljaf253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:28:22Z","timestamp":1760704102000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/193\/5\/936\/8176840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,6,27]]},"published-print":{"date-parts":[[2025,10,17]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf253","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,6,27]]}}}